Precision medicine in the treatment stratification of AML patients: challenges and progress
Open Access
- 28 December 2018
- journal article
- review article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (102) , 37790-37797
Abstract
Precision medicine in the treatment stratification of AML patients: challenges and progress Precision medicine in the treatment stratification of AML patients: challenges and progressKeywords
This publication has 58 references indexed in Scilit:
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaNew England Journal of Medicine, 2013
- The Origin and Evolution of Mutations in Acute Myeloid LeukemiaCell, 2012
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid LeukemiaNew England Journal of Medicine, 2012
- Use of Whole-Genome Sequencing to Diagnose a Cryptic Fusion OncogeneJAMA, 2011
- Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinomaInternational Journal of Cancer, 2008
- Prediction of individual response to chemotherapy in patients with acute myeloid leukaemia using the chemosensitivity index CiBritish Journal of Haematology, 2005
- Methylation of the hMLH1 promoter and its association with microsatellite instability in acute myeloid leukemiaLeukemia, 2003
- Role of FLT3 in leukemiaCurrent Opinion in Hematology, 2002
- Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed acute myeloid leukemia; involvement of the WIT-1 geneOncogene, 1999
- Laboratory prediction of clinical chemotherapeutic drug resistance: a working model exemplified by acute leukaemiaEuropean Journal of Cancer, 1993